Resistance to chloroquine unhinges vivax malaria therapeutics.
作者信息
Baird J Kevin
机构信息
Eijkman-Oxford Clinical Research Unit, Jalan Diponegoro No. 69, Jakarta 10430 Indonesia.
出版信息
Antimicrob Agents Chemother. 2011 May;55(5):1827-30. doi: 10.1128/AAC.01296-10. Epub 2011 Mar 7.
Abstract
摘要
相似文献
1
Resistance to chloroquine unhinges vivax malaria therapeutics.对氯喹的耐药性使间日疟治疗陷入困境。
Antimicrob Agents Chemother. 2011 May;55(5):1827-30. doi: 10.1128/AAC.01296-10. Epub 2011 Mar 7.
2
Primaquine in vivax malaria: an update and review on management issues.疟原虫感染的治疗：关于管理问题的更新和综述。
Malar J. 2011 Dec 12;10:351. doi: 10.1186/1475-2875-10-351.
3
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.氯喹剂量和伯氨喹对间日疟原虫复发的影响：全球抗疟药物耐药性网络系统评价和个体患者合并荟萃分析。
Lancet Infect Dis. 2018 Sep;18(9):1025-1034. doi: 10.1016/S1473-3099(18)30348-7. Epub 2018 Jul 20.
4
Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.监测氯喹-伯氨喹疗法对巴西主要传播热点地区无并发症间日疟原虫疟疾的疗效。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.01965-18. Print 2019 May.
5
Chloroquine-resistant Plasmodium vivax, Brazilian Amazon.巴西亚马逊地区的抗氯喹间日疟原虫
Emerg Infect Dis. 2007 Jul;13(7):1125-6. doi: 10.3201/eid1307.061386.
6
Drug resistant Plasmodium vivax malaria.抗药间日疟原虫疟疾
J Antimicrob Chemother. 1997 Dec;40(6):749-52. doi: 10.1093/jac/40.6.749.
7
Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.氯喹对泰国间日疟的治疗效果评估。
Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):566-9.
8
Imported tertian malaria resistant to primaquine.对伯氨喹耐药的输入性间日疟
Korean J Intern Med. 1999 Jul;14(2):86-9. doi: 10.3904/kjim.1999.14.2.86.
9
Treatment of primaquine-resistant Plasmodium vivax malaria.
Lancet. 1992 Aug 1;340(8814):310. doi: 10.1016/0140-6736(92)92404-4.
10
Prospective Study of Plasmodium vivax Malaria Recurrence after Radical Treatment with a Chloroquine-Primaquine Standard Regimen in Turbo, Colombia.在哥伦比亚图尔博采用氯喹-伯氨喹标准疗法进行根治治疗后间日疟复发的前瞻性研究
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4610-9. doi: 10.1128/AAC.00186-16. Print 2016 Aug.
引用本文的文献
1
A review of malaria epidemiology and control in Papua New Guinea 1900 to 2021: Progress made and future directions.1900年至2021年巴布亚新几内亚疟疾流行病学与防控综述：取得的进展与未来方向
Front Epidemiol. 2022 Oct 31;2:980795. doi: 10.3389/fepid.2022.980795. eCollection 2022.
2
The assessment of antimalarial drug efficacy in vivo.体内抗疟药物功效评估。
Trends Parasitol. 2022 Aug;38(8):660-672. doi: 10.1016/j.pt.2022.05.008. Epub 2022 Jun 6.
3
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets.通过多靶点鉴定具有抗SARS-CoV-2能力的化合物的药物再利用
Pharmaceutics. 2022 Jan 12;14(1):176. doi: 10.3390/pharmaceutics14010176.
4
Molecular Surveillance and Drug Susceptibilities of Isolates From the China-Myanmar Border.中缅边境分离株的分子监测和药物敏感性。
Front Cell Infect Microbiol. 2021 Nov 1;11:738075. doi: 10.3389/fcimb.2021.738075. eCollection 2021.
5
Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro.探究间日疟原虫肝脏期寄生虫的独特化学敏感性，并在体外证明 8-氨基喹啉自由基治愈活性。
Sci Rep. 2021 Oct 7;11(1):19905. doi: 10.1038/s41598-021-99152-9.
6
Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes.中缅边境地区间日疟原虫分离株的体外药敏试验及与 Pvmdr1 和 Pvcrt-o 基因多态性的关系。
PLoS Negl Trop Dis. 2020 Jun 12;14(6):e0008255. doi: 10.1371/journal.pntd.0008255. eCollection 2020 Jun.
7
Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate.间日疟原虫HAP2作为传播阻断疫苗候选物的评估
Vaccine. 2020 Mar 17;38(13):2841-2848. doi: 10.1016/j.vaccine.2020.02.011. Epub 2020 Feb 21.
8
8-Aminoquinoline Therapy for Latent Malaria.8-氨基喹啉疗法治疗潜伏疟疾。
Clin Microbiol Rev. 2019 Jul 31;32(4). doi: 10.1128/CMR.00011-19. Print 2019 Sep 18.
9
Analysis of Global Research on Malaria and .疟疾及. 的全球研究分析。
Int J Environ Res Public Health. 2019 May 31;16(11):1928. doi: 10.3390/ijerph16111928.
10
Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.根治后间日疟发病率：越南北中部的一项队列研究。
PLoS Med. 2019 May 17;16(5):e1002784. doi: 10.1371/journal.pmed.1002784. eCollection 2019 May.
本文引用的文献
1
Pamaquin; curative antimalarial activity in vivax malaria.扑疟喹；对间日疟有治疗性抗疟活性。
Fed Proc. 1946;5(1 Pt 2):165.
2
Shrinking the malaria map: progress and prospects.缩小疟疾地图：进展与展望。
Lancet. 2010 Nov 6;376(9752):1566-78. doi: 10.1016/S0140-6736(10)61270-6. Epub 2010 Oct 28.
3
Chloroquine for treatment of acute attacks of vivax malaria.氯喹用于治疗间日疟急性发作。
J Am Med Assoc. 1946 Jul 20;131:963-7. doi: 10.1001/jama.1946.02870290013005.
4
Chemotherapy in malaria.疟疾的化学疗法
Bull N Y Acad Med. 1946 Jul;22:345-57.
5
The international limits and population at risk of Plasmodium vivax transmission in 2009.2009 年按蚊传播间日疟原虫的国际界限和危险人群。
PLoS Negl Trop Dis. 2010 Aug 3;4(8):e774. doi: 10.1371/journal.pntd.0000774.
6
Malaria treatment by using artemisinin in Indonesia.印度尼西亚使用青蒿素治疗疟疾。
Acta Med Indones. 2010 Jan;42(1):51-6.
7
The Chesson strain of Plasmodium vivax malaria; relationship between prepatent period, latent period and relapse rate.间日疟原虫切森株；潜伏期、潜隐期与复发率之间的关系。
J Infect Dis. 1947 May-Jun;80(3):228-36. doi: 10.1093/infdis/80.3.228.
8
Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance.严重的间日疟原虫疟疾表现出明显的炎症失衡。
Malar J. 2010 Jan 13;9:13. doi: 10.1186/1475-2875-9-13.
9
Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria.间日疟原虫疟疾所致致命性呼吸窘迫的组织病理学
Am J Trop Med Hyg. 2009 Nov;81(5):758-62. doi: 10.4269/ajtmh.2009.09-0348.
10
Resistance to therapies for infection by Plasmodium vivax.间日疟原虫感染治疗的耐药性。
Clin Microbiol Rev. 2009 Jul;22(3):508-34. doi: 10.1128/CMR.00008-09.
Zotero 插件